Equity Overview
Price & Market Data
Price: $19.09
Daily Change: -$4.07 / 21.32%
Daily Range: $19.00 - $23.40
Market Cap: $432,455,296
Daily Volume: 152,917
Performance Metrics
1 Week: -1.22%
1 Month: 1.72%
3 Months: 15.55%
6 Months: -53.17%
1 Year: 32.77%
YTD: -52.52%
Company Details
Employees: 51
Sector: Commercial services
Industry: Miscellaneous commercial services
Country:
Details
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.